share_log

Medical Properties Trust Inc | 4: Statement of changes in beneficial ownership of securities-Officer Aldag Edward K JR

Medical Properties Trust Inc | 4: Statement of changes in beneficial ownership of securities-Officer Aldag Edward K JR

Medical Properties Trust | 4：持股變動聲明-高管 Aldag Edward K JR
美股SEC公告 ·  10/04 05:03
牛牛AI助理已提取核心訊息
Edward K. Aldag Jr., Chairman, President & CEO of Medical Properties Trust Inc (MPW), completed a stock sale transaction on October 2, 2024. The transaction involved the sale of 51,092 shares of common stock at a price of $5.90 per share. Following the sale, Aldag's direct holdings in the company amount to 4,805,041 shares. The total market value of the disposed shares was calculated at approximately $301,442.80. The sale was conducted under the transaction code 'F', which typically indicates a payment of exercise price or tax liability by delivering or withholding securities.
Edward K. Aldag Jr., Chairman, President & CEO of Medical Properties Trust Inc (MPW), completed a stock sale transaction on October 2, 2024. The transaction involved the sale of 51,092 shares of common stock at a price of $5.90 per share. Following the sale, Aldag's direct holdings in the company amount to 4,805,041 shares. The total market value of the disposed shares was calculated at approximately $301,442.80. The sale was conducted under the transaction code 'F', which typically indicates a payment of exercise price or tax liability by delivering or withholding securities.
Edward K. Aldag Jr.，Medical Properties Trust的董事長、總裁兼首席執行官（MPW），於2024年10月2日完成了一筆股票交易。該交易涉及以每股5.90美元的價格出售了51,092股普通股。銷售後，Aldag在公司的直接持股數量爲4,805,041股。已出售股份的總市值約爲301,442.80美元。該銷售是根據交易代碼'F'進行的，通常表示通過交付或扣減證券支付行權價格或稅務責任。
Edward K. Aldag Jr.，Medical Properties Trust的董事長、總裁兼首席執行官（MPW），於2024年10月2日完成了一筆股票交易。該交易涉及以每股5.90美元的價格出售了51,092股普通股。銷售後，Aldag在公司的直接持股數量爲4,805,041股。已出售股份的總市值約爲301,442.80美元。該銷售是根據交易代碼'F'進行的，通常表示通過交付或扣減證券支付行權價格或稅務責任。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

譯文內容由第三人軟體翻譯。


牛牛AI助手部分由第三方人工智慧模型基於資訊內容自動產生，只对除中国内地以外的地区提供。


以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。